This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

HomeBrowseAboutFAQs
Log In
Sign Up
Esophageal Carcinoma

A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous Carcinoma

Sponsored by Shandong Luye Pharmaceutical Co., Ltd.

About this trial

Last updated 17 years ago

Study ID

CMNa-ESO-01-2007

Status

Unknown status

Type

Interventional

Phase

Phase 4

Placebo

Yes

Accepting

18-75 Years
18 to 70 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 15 years ago

What is this trial about?

This multicentered clinical trial is going to find out the radio-sensitization action of sodium glycididazole in radiochemotherapy for esophageal cancer.

What are the participation requirements?

Yes

Inclusion Criteria

- written informed consent

- photographically and histologically proven thoracic esophageal squamous carcinoma

- stages 2a-3, and stage 4 with only supraclavicular lymph nodes metastasis defined by AJCC(2002)

- radiochemotherapy indication

- measurable tumor

- adequate hematologic, hepatic and renal function

- Karnofsky performance status ≥70

- age more than 18years and less than 70 years

No

Exclusion Criteria

- pregnancy and lactation

- significant neurologic disease

- severe liver and renal malfunction,and Significant medical illness

- previous chemotherapy, radiotherapy or immunotherapy

- esophagus hemorrhage and esophagus perforation features